Exhibit 99.1

 

LOGO

 

Contact: Tim Berryman
Director – Investor Relations
Medical Properties Trust, Inc.
(205) 969-3755
tberryman@medicalpropertiestrust.com

MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS

Per Share Net Income of $0.20 and Normalized FFO of $0.33

Continues to Deliver Accretive Acquisitions; $5 Billion Pipeline Opportunities

Birmingham, AL – October 31, 2019 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the third quarter ended September 30, 2019 and recent highlights.

“We are delighted with where we stand at the end of the third quarter of this record breaking year,” said Edward K. Aldag, Jr., MPT’s Chairman, President and Chief Executive Officer. “On top of the $3.4 billion of previously announced accretive investments, we added another $282 million in high-quality assets recently and are poised for even more significant acquisitions soon.”

Year-to-date, MPT has acquired and leased to well-positioned hospital operators approximately $3.7 billion of hospital real estate, a growth in assets of 40% since the beginning of the year. The acquired facilities, which are 100% leased, generate an average GAAP rate of approximately 8.0% resulting in immediately accretive results to Normalized FFO per share. Notwithstanding the record level of investments and FFO and dividend growth already achieved in 2019, the Company expects additional near-term acquisition opportunities as described by Aldag. “The market activity for hospital real estate continues to expand as operators across the globe recognize opportunities to access low cost permanent capital through efficient use of their real estate assets,” said Aldag. “MPT’s demonstrated ability to execute large acquisitions promptly and with certainty has provided us a competitive advantage over other hospital investors and has led to our commanding market share. We continue to actively pursue transactions totaling as much as $5.0 billion, some of which may close during the next few quarters.”

THIRD QUARTER AND RECENT HIGHLIGHTS

 

   

Net income of $0.20 and Normalized Funds from Operations (“NFFO”) of $0.33 in the third quarter, both on a per diluted share basis;

 

   

Acquired three inpatient rehabilitation facilities for $196 million and seven long-term acute care facilities for $58 million, with lease coverages of approximately two times and five times, respectively;

 

1


   

Commenced development of a $28 million, 92-bed freestanding behavioral health facility in Houston, Texas to be operated by NeuroPsychiatric Hospitals with an estimated opening in the third quarter of 2020;

 

   

Completed the previously announced investment in real estate and other assets of Watsonville Community Hospital for $55 million;

 

   

Sold $250 million of equity in the third quarter under MPT’s “at-the market” program at an average price of $18.62.

Previously announced acquisitions and capital markets activities completed in the third quarter:

 

   

$423 million acquisition of eight acute care hospitals in the UK operated by Ramsay Health Care;

 

   

$1.55 billion acquisition of 14 acute care hospitals and two behavioral health hospital facilities operated by Prospect Medical Holdings, Inc.;

 

   

51.75 million share issuance of common stock for net proceeds of approximately $858 million;

 

   

$900 million issuance of 4.625% senior notes due 2029 at issue price of 99.5% of par value for net proceeds of approximately $885 million.

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to NFFO, all on a basis comparable to 2018 results. In addition, a reconciliation of pro forma total gross assets to total assets is included in the financial tables accompanying this press release.

PORTFOLIO UPDATE

The Company has pro forma total gross assets of approximately $13.6 billion, including $10.5 billion in general acute care hospitals, $1.7 billion in inpatient rehabilitation hospitals, and $0.4 billion in long-term acute care hospitals. This pro forma portfolio includes 349 properties representing approximately 39,000 licensed beds in 33 U.S. states and in Germany, the United Kingdom, Switzerland, Italy, Spain and Australia.

OPERATING RESULTS AND OUTLOOK

Net income for the third quarter of 2019 was $89.8 million (or $0.20 per diluted share), compared to $736.0 million (or $2.00 per diluted share) in the third quarter of 2018 resulting from $695.2 million of gains from sales that include a joint venture transaction by which MPT sold a 50% interest in a portfolio of 71 German post-acute hospitals.

NFFO for the third quarter of 2019 was $147.5 million compared to $127.2 million in the third quarter of 2018. Per share NFFO was $0.33 per diluted share in the third quarter of 2019, compared to $0.35 per diluted share in the third quarter of 2018.

The Company expects an annual run-rate of $1.10 to $1.12 per diluted share for net income and $1.56 to $1.58 per diluted share for NFFO based on year-to-date transactions in 2019.

A reconciliation of NFFO guidance to net income is included with the financial tables accompanying this press release.

 

2


These estimates do not include the effects, if any, of unexpected real estate operating costs, changes in accounting pronouncements, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates may change if the Company acquires or sells assets in amounts that are different from estimates, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from our equity investments vary from expectations, or existing leases do not perform in accordance with their terms.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for Thursday, October 31, 2019 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended September 30, 2019. The dial-in numbers for the conference call are 844-535-3969 (U.S. and Canada) and 409-937-8903 (International); both numbers require passcode 4549247. The conference call will also be available via webcast in the Investor Relations’ section of the Company’s website, www.medicalpropertiestrust.com.

A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through November 14, 2019. Dial-in numbers for the replay are 855-859-2056 and 404-537-3406 for U.S./Canada and International callers, respectively. The replay passcode for all callers is 4549247.

The Company’s supplemental information package for the current period will also be available on the Company’s website under the “Investor Relations” section.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to acquire and develop net-leased hospital facilities. The Company’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions to, and the timely closing (if at all) of transactions; annual run-rate net income and NFFO per share; the amount of acquisitions of healthcare real estate, if any; results from potential sales and joint venture arrangements, if any; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in equity investments and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for income tax

 

3


purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.

# # #

 

4


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

 

(Amounts in thousands, except for per share data)    September 30, 2019     December 31, 2018  
     (Unaudited)     (A)  

Assets

    

Real estate assets

    

Land, buildings and improvements, intangible lease assets, and other

   $ 7,310,604     $ 5,268,459  

Mortgage loans

     1,268,563       1,213,322  

Net investment in direct financing leases

     688,891       684,053  

Investment in sale leaseback transactions

     1,390,619       —    
  

 

 

   

 

 

 

Gross investment in real estate assets

     10,658,677       7,165,834  

Accumulated depreciation and amortization

     (571,589     (464,984
  

 

 

   

 

 

 

Net investment in real estate assets

     10,087,088       6,700,850  

Cash and cash equivalents

     461,622       820,868  

Interest and rent receivables

     25,653       25,855  

Straight-line rent receivables

     299,993       220,848  

Equity investments

     777,102       520,058  

Other loans

     521,398       373,198  

Other assets

     279,297       181,966  
  

 

 

   

 

 

 

Total Assets

   $ 12,452,153     $ 8,843,643  
  

 

 

   

 

 

 

Liabilities and Equity

    

Liabilities

    

Debt, net

   $ 6,096,232     $ 4,037,389  

Accounts payable and accrued expenses

     249,642       204,325  

Deferred revenue

     16,377       13,467  

Obligations to tenants and other lease liabilities

     103,084       27,524  
  

 

 

   

 

 

 

Total Liabilities

     6,465,335       4,282,705  

Equity

    

Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding

     —         —    

Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 459,778 shares at September 30, 2019 and 370,637 shares at December 31, 2018

     460       371  

Additional paid-in capital

     5,972,341       4,442,948  

Retained earnings

     51,702       162,768  

Accumulated other comprehensive loss

     (50,186     (58,202

Treasury shares, at cost

     (777     (777
  

 

 

   

 

 

 

Total Medical Properties Trust, Inc. Stockholders’ Equity

     5,973,540       4,547,108  

Non-controlling interests

     13,278       13,830  
  

 

 

   

 

 

 

Total Equity

     5,986,818       4,560,938  
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 12,452,153     $ 8,843,643  
  

 

 

   

 

 

 

(A) Financials have been derived from the prior year audited financial statements.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

 

(Amounts in thousands, except for per share data)    For the Three Months Ended     For the Nine Months Ended  
     September 30, 2019     September 30, 2018     September 30, 2019     September 30, 2018  

Revenues

        

Rent billed

   $ 124,361     $ 118,238     $ 343,841     $ 369,076  

Straight-line rent

     31,026       18,293       76,813       49,157  

Income from direct financing leases

     17,502       18,998       52,168       55,613  

Interest and other income

     51,867       41,467       124,937       130,098  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     224,756       196,996       597,759       603,944  

Expenses

        

Interest

     64,519       57,215       167,396       172,364  

Real estate depreciation and amortization

     40,833       29,949       108,161       100,217  

Property-related (A)

     4,038       2,719       15,394       6,823  

General and administrative

     23,286       20,982       69,009       58,352  

Acquisition costs

     —         506       —         917  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     132,676       111,371       359,960       338,673  

Other income (expense)

        

Gain on sale of real estate and other, net

     209       647,204       62       672,822  

Earnings from equity interests

     3,474       3,116       11,635       10,542  

Unutilized financing fees

     (3,959     —         (4,873     —    

Other

     (2,282     2,595       (1,497     (4,297
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other income

     (2,558     652,915       5,327       679,067  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income tax

     89,522       738,540       243,126       944,338  

Income tax benefit (expense)

     745       (2,064     3,352       (4,802
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     90,267       736,476       246,478       939,536  

Net income attributable to non-controlling interests

     (481     (442     (1,432     (1,334
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to MPT common stockholders

   $ 89,786     $ 736,034     $ 245,046     $ 938,202  
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share - basic:

        

Net income attributable to MPT common stockholders

   $ 0.20     $ 2.01     $ 0.60     $ 2.56  
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share - diluted:

        

Net income attributable to MPT common stockholders

   $ 0.20     $ 2.00     $ 0.60     $ 2.56  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding - basic

     439,581       365,024       404,902       364,934  

Weighted average shares outstanding - diluted

     440,933       366,467       406,100       365,784  

Dividends declared per common share

   $ 0.26     $ 0.25     $ 0.76     $ 0.75  

(A) Includes $2.9 million and $11.4 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three and nine months ended September 30, 2019, respectively. These costs are required to be presented on a gross basis (with offset included in Interest and other income), following our adoption of the new lease accounting standard on January 1, 2019. We presented similar items in the prior year on a net basis.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Reconciliation of Net Income to Funds From Operations

(Unaudited)

 

(Amounts in thousands, except for per share data)    For the Three Months Ended     For the Nine Months Ended  
     September 30, 2019     September 30, 2018     September 30, 2019     September 30, 2018  

FFO information:

        

Net income attributable to MPT common stockholders

   $ 89,786     $ 736,034     $ 245,046     $ 938,202  

Participating securities’ share in earnings

     (432     (290     (1,354     (808
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income, less participating securities’ share in earnings

   $ 89,354     $ 735,744     $ 243,692     $ 937,394  

Depreciation and amortization

     50,163       32,641       130,424       104,314  

Gain on sale of real estate and other, net

     (209     (647,204     (62     (672,822
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 139,308     $ 121,181     $ 374,054     $ 368,886  

Write-off of straight-line rent and other, net of tax benefit

     4,230       4,321       7,232       17,615  

Unutilized financing fees

     3,959       —         4,873       —    

Acquisition costs, net of tax benefit

     —         1,661       —         2,072  
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 147,497     $ 127,163     $ 386,159     $ 388,573  

Share-based compensation

     9,087       4,970       22,119       11,695  

Debt costs amortization

     2,659       1,952       6,914       5,543  

Straight-line rent revenue and other

     (39,204     (26,743     (96,762     (74,544
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 120,039     $ 107,342     $ 318,430     $ 331,267  
  

 

 

   

 

 

   

 

 

   

 

 

 

Per diluted share data:

        

Net income, less participating securities’ share in earnings

   $ 0.20     $ 2.00     $ 0.60     $ 2.56  

Depreciation and amortization

     0.12       0.09       0.32       0.29  

Gain on sale of real estate and other, net

     —         (1.76     —         (1.84
  

 

 

   

 

 

   

 

 

   

 

 

 

Funds from operations

   $ 0.32     $ 0.33     $ 0.92     $ 1.01  

Write-off of straight-line rent and other, net of tax benefit

     0.01       0.01       0.02       0.04  

Unutilized financing fees

     —         —         0.01       —    

Acquisition costs, net of tax benefit

     —         0.01       —         0.01  
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized funds from operations

   $ 0.33     $ 0.35     $ 0.95     $ 1.06  

Share-based compensation

     0.02       0.01       0.05       0.03  

Debt costs amortization

     0.01       0.01       0.02       0.02  

Straight-line rent revenue and other

     (0.09     (0.08     (0.24     (0.20
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted funds from operations

   $ 0.27     $ 0.29     $ 0.78     $ 0.91  
  

 

 

   

 

 

   

 

 

   

 

 

 

Notes:

(A) Certain line items above (such as real estate depreciation) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with the activity of all of our equity interests in the “Earnings from equity interests” line on the consolidated statements of income.

(B) Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) non-cash revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.


MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Annual Run-Rate Guidance Reconciliation

(Unaudited)

 

     Annual Run-Rate Guidance - Per  Share(1)  
     Low      High  

Net income attributable to MPT common stockholders

   $ 1.10      $ 1.12  

Participating securities’ share in earnings

     —          —    
  

 

 

    

 

 

 

Net income, less participating securities’ share in earnings

   $ 1.10      $ 1.12  

Depreciation and amortization

     0.46        0.46  
  

 

 

    

 

 

 

Funds from operations

   $ 1.56      $ 1.58  

Other adjustments

     —          —    
  

 

 

    

 

 

 

Normalized funds from operations

   $ 1.56      $ 1.58  
  

 

 

    

 

 

 

 

  (1)

The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance.

Pro Forma Total Gross Assets

(Unaudited)

 

(Amounts in thousands)    September 30, 2019  

Total Assets

   $ 12,452,153  

Add:

  

Binding real estate commitments on new investments(2)

     27,500  

Unfunded amounts on development deals and commenced capital improvement projects(3)

     130,096  

Accumulated depreciation and amortization

     571,589  

Incremental gross assets of our joint ventures(4)

     530,593  

Less:

  

Cash and cash equivalents

     (157,596
  

 

 

 

Pro Forma Total Gross Assets(5)

   $ 13,554,335  
  

 

 

 

 

  (2)

Reflects a commitment to finance the development of a facility in Texas.

  (3)

Includes $43.3 million unfunded amounts on ongoing development projects and $86.8 million unfunded amounts on capital improvement projects and development projects that have commenced rent.

  (4)

Adjustment needed to reflect our share of our joint ventures’ gross assets.

  (5)

Pro forma total gross assets is total assets before accumulated depreciation/amortization and assumes all real estate binding commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded. We believe pro forma total gross assets is useful to investors as it provides a more current view of our portfolio and allows for a better understanding of our concentration levels as our binding commitments close and our other commitments are fully funded.

View differences made from one to another to evaluate Medical Properties Trust Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Medical Properties Trust Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Log in with your credentials

or    

Forgot your details?

Create Account